Last reviewed · How we verify
hand antiseptic with CHG and alcohol
Solventum US LLC's hand antiseptic with CHG and alcohol is currently on the market, positioning the company in the competitive hand hygiene sector. A key strength is the protection of its core composition through a patent expiring in 2028, providing a barrier to entry for generic competitors. The primary risk lies in the lack of disclosed revenue and key trial results, which may limit investor confidence and market differentiation.
At a glance
| Generic name | hand antiseptic with CHG and alcohol |
|---|---|
| Also known as | Avagard CHG Hand Antiseptic with Moisturizers, Purell Advanced Instant Hand Sanitizer Foam |
| Sponsor | Solventum US LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- hand antiseptic with CHG and alcohol CI brief — competitive landscape report
- hand antiseptic with CHG and alcohol updates RSS · CI watch RSS
- Solventum US LLC portfolio CI